BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 28360086)

  • 1. Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
    Cheng S; Shah SH; Corwin EJ; Fiehn O; Fitzgerald RL; Gerszten RE; Illig T; Rhee EP; Srinivas PR; Wang TJ; Jain M;
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28360086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into cardiovascular and lipid metabolomics.
    Giovane A; Balestrieri A; Napoli C
    J Cell Biochem; 2008 Oct; 105(3):648-54. PubMed ID: 18729082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association.
    Musunuru K; Ingelsson E; Fornage M; Liu P; Murphy AM; Newby LK; Newton-Cheh C; Perez MV; Voora D; Woo D;
    Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28760750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease.
    Ussher JR; Elmariah S; Gerszten RE; Dyck JR
    J Am Coll Cardiol; 2016 Dec; 68(25):2850-2870. PubMed ID: 28007146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
    Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
    Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
    Quinones MP; Kaddurah-Daouk R
    Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Lackland DT; Elkind MS; D'Agostino R; Dhamoon MS; Goff DC; Higashida RT; McClure LA; Mitchell PH; Sacco RL; Sila CA; Smith SC; Tanne D; Tirschwell DL; Touzé E; Wechsler LR; ; ; ; ; ;
    Stroke; 2012 Jul; 43(7):1998-2027. PubMed ID: 22627990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics and cardiovascular biomarker discovery.
    Rhee EP; Gerszten RE
    Clin Chem; 2012 Jan; 58(1):139-47. PubMed ID: 22110018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Livestock metabolomics and the livestock metabolome: A systematic review.
    Goldansaz SA; Guo AC; Sajed T; Steele MA; Plastow GS; Wishart DS
    PLoS One; 2017; 12(5):e0177675. PubMed ID: 28531195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METABOLOMICS IN MEDICAL SCIENCES--TRENDS, CHALLENGES AND PERSPECTIVES.
    Klupczyńska A; Dereziński P; Kokot ZJ
    Acta Pol Pharm; 2015; 72(4):629-41. PubMed ID: 26647618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontiers of high-throughput metabolomics.
    Zampieri M; Sekar K; Zamboni N; Sauer U
    Curr Opin Chem Biol; 2017 Feb; 36():15-23. PubMed ID: 28064089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (1)H-NMR-based metabolomic analysis of the effect of moderate wine consumption on subjects with cardiovascular risk factors.
    Vázquez-Fresno R; Llorach R; Alcaro F; Rodríguez MÁ; Vinaixa M; Chiva-Blanch G; Estruch R; Correig X; Andrés-Lacueva C
    Electrophoresis; 2012 Aug; 33(15):2345-54. PubMed ID: 22887155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics: a new era in cardiology?
    Mercuro G; Bassareo PP; Deidda M; Cadeddu C; Barberini L; Atzori L
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):800-5. PubMed ID: 21934525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking of metabolomic biomarkers with cardiometabolic health in Chinese population.
    Sun L; Li H; Lin X
    J Diabetes; 2019 Apr; 11(4):280-291. PubMed ID: 30239137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics in cardiovascular diseases.
    Kordalewska M; Markuszewski MJ
    J Pharm Biomed Anal; 2015 Sep; 113():121-36. PubMed ID: 25958299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.
    Dona AC; Coffey S; Figtree G
    Eur J Prev Cardiol; 2016 Oct; 23(15):1578-89. PubMed ID: 27103630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society.
    Rich MW; Chyun DA; Skolnick AH; Alexander KP; Forman DE; Kitzman DW; Maurer MS; McClurken JB; Resnick BM; Shen WK; Tirschwell DL;
    Circulation; 2016 May; 133(21):2103-22. PubMed ID: 27067230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of gut microbial metabolites in cardiometabolic health and translational research.
    Wu WK; Hsu CC; Sheen LY; Wu MS
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8537. PubMed ID: 31344762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and developments in tandem mass spectrometry based clinical metabolomics.
    Ceglarek U; Leichtle A; Brügel M; Kortz L; Brauer R; Bresler K; Thiery J; Fiedler GM
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):266-71. PubMed ID: 19007853
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.